THERAPEUTIC BIOFEEDBACK AND THE SINGLE-SUBJECT STRATEGY

    loading  Checking for direct PDF access through Ovid

Abstract

The present paper contends that therapeutic biofeedback studies have not isolated the active treatment component from within a multiple-treatment approach. Resolving this dilemma requires carefully controlled studies with the correspondingly unpleasant dilemma of assigning troubled individuals to control groups. With this in mind, and in order to begin the isolation of the efficacious treatment component, a singlet-composite (A-B-BCD) single-subject strategy is described. While limitations are noted, use of the singlet-composite design with varied replications is offered as the single-subject strategy of choice for therapeutic biofeedback in particular and for multiple-treatment therapies in general.

Related Topics

    loading  Loading Related Articles